ATC code B

ATC code relating to drugs affecting the blood and blood forming organs
Pharmaceutical drug classification
ATC code B: Blood and blood forming organs
  • B01 Antithrombotic agents
  • B02 Antihemorrhagics
  • B03 Antianemic preparations
  • B05 Blood substitutes and perfusion solutions
  • B06 Other hematological agents
Other ATC codes

ATC code B Blood and blood forming organs is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3][4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QB.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

References

  1. ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
  2. ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
  3. ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
  4. ^ "ATC/DDD Index 2022: code B". WHO Collaborating Centre for Drug Statistics Methodology.
  5. ^ "ATCvet Index 2022: code QB". WHO Collaborating Centre for Drug Statistics Methodology.
  • v
  • t
  • e
Major chemical drug groups – based upon the Anatomical Therapeutic Chemical Classification System
gastrointestinal tract
/ metabolism (A)blood and blood
forming organs (B)cardiovascular
system (C)skin (D)genitourinary
system (G)endocrine
system (H)infections and
infestations (J, P, QI)malignant disease
(L01–L02)immune disease
(L03–L04)muscles, bones,
and joints (M)brain and
nervous system (N)respiratory
system (R)sensory organs (S)other ATC (V)
  •  Drugs
  • Pharmacological classification systems
  • ATC codes
  •  Medicine portal
  • v
  • t
  • e
Antiplatelet drugs
Glycoprotein IIb/IIIa inhibitors
ADP receptor/P2Y12 inhibitors
Prostaglandin analogue (PGI2)
COX inhibitors
Thromboxane inhibitors
Phosphodiesterase inhibitors
Other
Anticoagulants
Vitamin K antagonists
(inhibit II, VII, IX, X)
Factor Xa inhibitors
(with some II inhibition)
Heparin group/
glycosaminoglycans/
(bind antithrombin)
Direct Xa inhibitors ("xabans")
Direct thrombin (IIa) inhibitors
Other
Thrombolytic drugs/
fibrinolytics
Non-medicinal
  • v
  • t
  • e
Antihemorrhagics
(coagulation)
Systemic
Vitamin K
  • Phytomenadione (K1)
  • Menadione (K3)
Coagulation
factors
Other
systemic
Local
Antifibrinolytics
  • v
  • t
  • e
Blood substitutes and perfusion solutions (B05)
Blood and related products (B05A)
Intravenous solutions (B05B)
Irrigating solutions (B05C)
Others (B05D, B05X)